无输血肝移植技术的初步探索
该回顾性研究纳入天津市第一中心医院2019年成人肝移植受者,比较无输血组(n=21)、输血组(n=28)与未采用输血管理策略的对照组(n=40)围手术期指标。结果显示无输血组和输血组术中出血量均少于对照组,无输血组ICU住院时间短于另两组,术后第7天ALT低于对照组。结论认为以不输血为目标的血液管理可减少术中出血并利于早期恢复。
要点
- 无输血组和输血组术中出血量均少于对照组,差异有统计学意义。
- 无输血组ICU住院时间短于输血组和对照组。
- 术后第7天无输血组ALT水平低于对照组。
核心结论
- 以不输血肝移植为目标的多学科输血管理技术改进可有效减少术中出血并有助于避免外科输血。
- 无输血肝移植有利于受者术后早期恢复,其长期临床意义有待进一步研究。
研究设计与样本
- 回顾性临床观察研究,纳入2019年8—12月天津市第一中心医院49例成人肝移植受者,按术中是否输血分为无输血组(n=21)和输血组(n=28)。
- 另选取2019年1—7月未采取输血管理策略的40例移植受者作为对照组。
- 无输血技术包括急性血液稀释或等容血液去除、维持降低的基线中心静脉压和血液回收等麻醉管理技术。
- 数据分析采用单因素方差分析、秩和检验和χ²检验。
主要发现
- 无输血组、输血组和对照组术中出血量分别为(454.2±271.3)ml、(673.6±333.4)ml和(890.3±346.7)ml,无输血组与输血组均少于对照组(q=-6.342、-5.286,P值均<0.05)。
- 无输血组、输血组和对照组ICU住院时间分别为(36.4±9.1)h、(44.3±14.9)h和(58.2±21.1)h,无输血组短于输血组和对照组(q=-4.432、-3.824,P值均<0.05)。
- 术后第7天无输血组ALT水平为(56.8±32.1)U/L,低于对照组的(89.6±45.6)U/L(q=-3.358,P<0.05)。
临床怎么用
- 肝移植术中可考虑采用急性血液稀释、低中心静脉压和血液回收等血液管理技术以减少出血和异体输血。
- 无输血策略可能缩短ICU住院时间并促进术后早期肝功能恢复。
局限性
- 本研究为单中心回顾性观察,样本量有限,结论需进一步前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluate the effect of transfusion-free techniques on the prognosis of liver transplant patients. Methods: The recipients of adult liver transplantation at Tianjin First Central Hospital from August to December 2019 were included in the clinical observation. Liver transplantation without allogeneic blood transfusion was performed through anesthesia management techniques such as acute hemodilution or phlebotomy without volume replacement,maintaining decreased baseline central venous pressure and cell saver. According to the actual results,the patients were divided into two groups: transfusion-free group(n=21) and allogeneic transfusion group(n=28). There were 13 males and 8 females aged of (56.3±11.6) years in the transfusion-free group;and there were 16 males and 12 females aged (54.3±14.2)years in the allogeneic transfusion group. The transplant recipients who had not adopted transfusion management strategy from January to July 2019 were included as control group(27 males and 13 females,aged of (58.9±14.1)years). The clinical data of patients in perioperative period were collected to compare whether there were differences in the recovery of liver function and early complications among the three groups, one-way ANOVA test, rank-sum test, and χ2 test were used for data analysis. Results: The amount of intraoperative blood loss in both the transfusion-free group and the transfusion group was less than that in the control group((454.2±271.3)ml vs.(673.6±333.4)ml vs.(890.3±346.7)ml;q=-6.342,-5.286,both P<0.05).The duration of stay in ICU of the transfusion-free group was less than that of the transfusion group and control group((36.4±9.1)hours vs.(44.3±14.9)hours vs.(58.2±21.1)hours;q=-4.432,-3.824,both P<0.05).The mean ALT level at 7 days after operation was significantly lower in the transfusion-free group than in the control group((56.8±32.1)U/L vs.(89.6±45.6)U/L;q=-3.358,P<0.05). Conclusions: The improvement of multi-disciplinary transfusion management technology aimed at transfusion-free liver transplantation can effectively reduce intraoperative hemorrhage and help to avoid surgical transfusion. Transfusion-free liver transplantation is beneficial to the early postoperative recovery,and its long-term clinical significance is worthy of further clinical research. 目的: 探讨减少或避免肝移植术中输注异体血的系列血液管理改进策略对受者围手术期指标的影响。 方法: 回顾性收集2019年8—12月天津市第一中心医院收治的49例成人肝移植受者资料。根据术中是否输血分为无输血组(21例)和输血组(28例)。无输血组男性13例,女性8例,年龄(56.3±11.6)岁;输血组男性16例,女性12例,年龄(54.3±14.2)岁。所有患者术中采用急性血液稀释、低中心静脉压、血液回收等麻醉管理技术,最大限度地减少肝移植术中出血量。随机选取2019年1—7月未采取输血管理策略的40例移植受者作为对照组,男性27例,女性13例,年龄(58.9±14.1)岁。收集各组患者的围手术期临床资料,比较三组移植术后早期的肝功能恢复及并发症等情况,分别采用方差分析、秩和检验、χ²检验进行数据分析。 结果: 无输血组与输血组术中出血量均少于对照组[出血量分别为(454.2±271.3)、(673.6±333.4)、(890.3±346.7)ml;q=-6.342、-5.286,P值均<0.05]。无输血组ICU住院时间短于输血组和对照组[ICU住院时间分别为(36.4±9.1)、(44.3±14.9)、(58.2±21.1)h;q=-4.432、-3.824,P值均<0.05],术后第7天无输血组的ALT水平低于对照组[(56.8±32.1)U/L比(89.6±45.6)U/L;q=-3.358,P<0.05]。 结论: 以不输血肝移植为目标开展多学科输血管理技术改进措施,可有效减少肝移植术中出血量,并有助于避免外科输血,且有利于受者术后早期恢复。.
引用
- Tian DZ, Teng DH, Yu Y, et al. [Initial exploration of transfusion-free liver transplantation]. Zhonghua Wai Ke Za Zhi. 2021. PMID: 33915624. doi:10.3760/cma.j.cn112139-20200525-00410
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。